Neurocognitive impairment is an independent risk factor for death in HIV infection

Archives of Neurology

Volumn 54, Issue 4, 1997, Pages 416-424

  Ellis, Ronald J ^a,b   Deutsch, Reena ^d   Heaton, Robert K ^b   Marcotte, Thomas D ^b   McCutchan, J Allen ^c   Nelson, Julie A ^f   Abramson, Ian ^d   Thal, Leon J ^a,f   Atkinson, J Hampton ^b   Wallace, Mark R ^e   Grant, Igor ^b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; DEATH; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; NEUROPSYCHIATRY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

EID: 0031002086     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550160054016     Document Type: Article

References (57)

1. Centers for Disease Control and Prevention. Update: trends in AIDS among men who have sex with men - United States, 1989-1994. MMWR Morb Mortal Wkly Rep. 1995;44:401-404.
2. Checko PJ. Human immunodeficiency virus (HIV) infection as a leading cause of death among young adults aged 25 to 44 years in Connecticut. Conn Med. 1994;58:661-663.
3. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
4. Nightingale SD, Jockusch JD, Haslund I, Cal SX, Peterson DM, Loss SD. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. Arch Intern Med. 1993;153:1313-1318.
5. Ehmann WC, Eyster ME, Wilson SE, Andes WA, Goedert JJ. Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV: Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr. 1994;7: 1095-1098.
6. DeGruttola V, Wulfsohn M, Fischl MA, Tsiatis A. Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr. 1993;6:359-365.
7. Luo K, Law M, Kaldor JM, McDonald AM, Cooper DA. The role of initial AIDS-defining illness in survival following AIDS. AIDS. 1995;9:57-63.
8. Blatt SP, McCarthy WF, Bucko-Krasnicka B, et al. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis. 1995;171:837-844.
9. Kerlikowske KM, Katz MH, Allen S, et al. Beta 2-microglobulin as a predictor of death in HIV-infected women from Kigali, Rwanda. AIDS. 1994;8:963-969.
10. Boufassa F, Bachmeyer C, Carre N, et al. Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression: SEROCO Study Group. J Infect Dis. 1995;171:1190-1195.
11. Casabona J, Sanchez E, Graus F, Abos J, Segura A. Trends and survival for AIDS patients presenting with indicative neurologic diseases. Acta Neurol Scand. 1991;84:51-55.
12. Karlsen NR, Reinvang I, Froland SS. A follow-up study of neuropsychological functioning in AIDS-patients: prognostic significance and effect of zidovudine therapy. Acta Neurol Scand. 1995;91:215-221.
13. Davis LE, Hjelle BL, Miller VE, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992;42:1736-1739.
14. Goudsmit J, deWolf F, Paul DA, et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 1986;2:177-180.
15. Johnson RT, McArthur JC, Narayan O. The neurobiology of human immunodeficiency virus infections. FASEB J. 1988;2:2970-2981.
16. Resrtick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain barrier by HIV. Neurology. 1988;38:9-14.
17. Chiodi F, Keys B, Albert J, et al. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol. 1992;30:1768-1771.
18. Heyes MP, Brew BJ, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991;29:202-209.
19. Sonnerborg AB, von Stedingk LV, Hansson LO, Strannegard OO. Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection. AIDS. 1989;3:277-283.
20. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 1990;250:1593-1596.
21. American Academy of Neurology. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection: report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41:778-785.
22. Grant I, Atkinson JH, Hesselink JR, et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections: studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987;107: 828-836.
23. Heaton R, Grant I, Butters N, et al. The HNRC 500: neuro psycho logy of HIV infection at different disease stages. J Int Neuropsychol Soc. 1995;1:231-251.
24. Wilkie FL, Eisdorfer C, Morgan R, Loewenstein DA, Szapocznik J. Cognition in early human immunodeficiency virus infection. Arch Neurol. 1990;47:433-440.
25. White DA, Heaton RK, Monsch AU. The HNRC Group: neuropsychological studies of asymptomatic human immunodeficiency virus type-1 infected individuals. J Int Neuropsychol Soc. 1995;1:304-315.
26. Stern Y, Liu X, Marder K, et al. Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infection. Neurology. 1995;45:467-472.
27. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors: Multicenter AIDS Cohort Study. Neurology. 1993;43: 2245-2252.
28. Mayeux R, Stern Y, Tang MX, et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology. 1993; 43:176-182.
29. Chelune GJ, Heaton RK, Lehman RAW. Neuropsychological and personality correlates of patients' complaints of disability. In: Goldstein G, ed. Advances in Clinical Neuropsychology. New York, NY: Plenum Press; 1986.
30. Keys A, Flaminio F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329-343.
31. Butters N, Grant I, Haxby J, et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. J Clin Exp Neuropsychol. 1990;12:963-978.
32. Heaton RK, Kirson D, Velin RA, Grant I, The HNRC Group: the utility of clinical ratings for detecting cognitive change in HIV infection. In: Grant I, Martin A, eds. Neuropsychology of HIV Infection. New York, NY: Oxford University Press Inc; 1994:188-206.
33. Heaton RK, Grant I, Mathews CG. Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Odessa, Fla: Psychological Assessment Resources Inc; 1991.
34. Heaton RK. Comprehensive Norms for an Expanded Halstead-Reitan Battery: A Supplement for the WAIS-R. Odessa, Fla: Psychological Assessment Resources Inc; 1992.
35. Heaton RK, Grant I, Anthony WZ, Lehman RA. A comparison of clinical and automated interpretation of the Halstead-Reitan Battery. J Clin Neuropsychol. 1981;3:121-141.
36. Filley CM, Heaton RK, Thompson LL, Nelson LM, Franklin GM. Effects of disease course on neuropsychological functioning. In: Rao SM, ed. Neurobehavioral Aspects of Multiple Sclerosis. New York, NY: Oxford University Press Inc; 1990:136-148.
37. Spitzer RL, Williams JB, Gibbon M, Furst MB. Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Association; 1990.
38. Association AP. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association Press; 1987.
39. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
41. Endicott J, Cohen J, Nee J, Fleiss J, Sarantakos S. Hamilton Depression Rating Scale: extracted from regular and change versions of the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry, 1981;38:98-103.
42. Hamilton M. General problems of psychiatric rating scales (especially for depression). Mod Probl Pharmacother. 1974;7:125-138.
43. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
44. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
45. Statistical Sciences Inc. S-PLUS. Seattle, Wash: Statistical Sciences Inc; 1992.
46. Newman SP, Lunn S, Harrison MJ. Do asymptomatic HIV-seropositive individuals show cognitive deficit? AIDS. 1995;9:1211-1220.
47. Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet 1994;344:1120-1124.
48. Melnick SL, Sherer R, Louis TA, et al. Survival and disease progression according to gender of patients with HIV infection: The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA. 1994;272:1915-1921.
49. Poutiainen E, Elovaara I. Subjective complaints of cognitive symptoms are related to psychometric findings of memory deficits in patients with HIV-1 infection. J Int Neuropsychol Soc. 1996;2:219-225.
50. Heaton RK, Velin RA, McCutchan JA, et al. Neuropsychological impairment in HIV-infection: implications for employment. Psychosom Med. 1994;56:8-17.
51. Thurstone LL. Primary Mental Abilities, Revised. Chicago, III: University of Chicago Press; 1969.
52. Wechsler D. Wechsler Adult Intelligence Scale - Revised. New York, NY: The Psychological Corp; 1981.
53. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia, Pa: Lea & Febiger; 1983.
54. Reitan R. Manual for Administration of Neuropsychological Test Batteries for Adults and Children. Tucson, Ariz: Neuropsychology Laboratory; 1979.
55. Gronwall DMA. Paced auditory serial addition task: a measure of recovery from concussion. Percept Motor Skills. 1977;44:367-373.
56. Klove H. Clinical neuropsychology. In: Forster FM, ed. The Medical Clinics of North America. Philadelphia, Pa: WB Saunders Co; 1963.
57. Kramer CY. Extension of multiple range tests to group means with unequal numbers of replications. Biometrics. 1956;12:309-310.